Fig. 3From: Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711Plasma CTX-I concentrations in response to repeat oral dosing once daily for 5 days with vehicle or MIV-711 (30 µmol/kg). Mean ± SEM, n = 4Back to article page